Diethylamine

Diethylamine

SCHEMBL3024754

CCCCCCOC(=O)c1ccccc1C(=O)c1ccccc1O.CCNCC

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.68
TSHR P16473 4/20 0.68
LMNA P02545 2/20 0.68
CYP3A4 P08684 2/20 0.65
MAPK1 P28482 2/20 0.65
TP53 P04637 1/20 0.65
TDP1 Q9NUW8 3/20 0.58
L3MBTL1 Q9Y468 3/20 0.58
KDM4E B2RXH2 3/20 0.56
HSD17B10 Q99714 2/20 0.56
POLB P06746 1/20 0.56
MAPT P10636 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NAAA Q02083 1/20 0.48
KDM4A O75164 1/20 0.47
KDM4C Q9H3R0 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL570966 0.94 ALDH1A1 (0.77) ALDH1A1TSHRLMNACYP3A4MAPK1
2-Hydroxybenzoic Acid Hexyl Ester SCHEMBL29085497 0.92 ALDH1A1 (0.70) ALDH1A1TSHRLMNACYP3A4MAPK1
SCHEMBL7459965 0.85 ALDH1A1 (0.81) ALDH1A1TSHRLMNACYP3A4MAPK1
SCHEMBL1005991 0.85 ALDH1A1 (0.81) ALDH1A1TSHRLMNACYP3A4MAPK1
SCHEMBL1923016 0.85 ALDH1A1 (0.81) ALDH1A1TSHRLMNACYP3A4MAPK1
SCHEMBL411474 0.85 ALDH1A1 (0.81) ALDH1A1TSHRLMNACYP3A4MAPK1
SCHEMBL4731100 0.85 ALDH1A1 (0.81) ALDH1A1TSHRLMNACYP3A4MAPK1
SCHEMBL8927962 0.85 ALDH1A1 (0.81) ALDH1A1TSHRLMNACYP3A4MAPK1
SCHEMBL2801630 0.85 ALDH1A1 (0.81) ALDH1A1TSHRLMNACYP3A4MAPK1
2-Hydroxybenzoic Acid Hexyl Ester SCHEMBL113059 0.85 ALDH1A1 (0.81) ALDH1A1TSHRLMNACYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4310072-A1 ULTRAVIOLET ABSORBER, COMPOSITION, COSMETIC PRODUCT, AND PROCESS FOR PREPARING COSMETIC PRODUCT MFCI (Huanggang) Co., Ltd. (CN) 2024-01-24 EP claimed
EP-4310072-A1 ULTRAVIOLET ABSORBER, COMPOSITION, COSMETIC PRODUCT, AND PROCESS FOR PREPARING COSMETIC PRODUCT MFCI (Huanggang) Co., Ltd. (CN) 2024-01-24 EP disclosed
US-20170105910-A1 UV FILTER CAPSULE BASF SE (DE) 2017-04-20 US disclosed
US-20100209463-A1 UV FILTER CAPSULE MERCK PATENT GMBH (DE) 2010-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170105910-A1 UV FILTER CAPSULE UROD, MITF, NISCH ALDH1A1 801/4885TSHR 3400/4885LMNA 1490/4885
US-20100209463-A1 UV FILTER CAPSULE UROD, MITF, NISCH ALDH1A1 801/4885TSHR 3400/4885LMNA 1490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.